Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) version 4 quality of life instrument into Arabic language

Overview of attention for article published in Health and Quality of Life Outcomes, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source
twitter: 17 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user
reddit: 1 Redditor

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Blogs Policy documents X Facebook Google+ Reddit Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

ruxolitinib

Cited by Canadian Agency for Drugs and Technologies in Health on 18 Jan 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

ruxolitinib

Cited by Canadian Agency for Drugs and Technologies in Health on 19 Oct 2022

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.